Intravaginal contraceptive and drug release device and method for making and using same

ABSTRACT

A contraceptive device and method of contraception as well as a method of making the contraceptive device are described. Native collagen form of fibrillar protein is comminuted and homogenized in an acid environment; noncollagenous material is removed and residual collagen is mixed with water the pH of the resulting slurry is adjusted to 4.5 to 5.0 by the addition of acetic acid; gluteraldehyde is then added and the slurry poured into molds and frozen at approximately -10° centigrade for approximately 20 hours. The frozen mass is then thawed, washed, and immersed in a wash of pH 8 to 9 for approximately 2 hours at 20° centigrade. Sufficient reducing agent is added to the wash to create excess reducing equivalents. The sponge is then immersed in a buffer solution of pH 4 to 5 for a time sufficient to equilibrate to uniform pH. The sponge formed by the above method is then moistened and self-administered in the upper vault of the vagina proximal to the cervix. The sponge is then retained for a desired period, usually several days to one month.

This is a division, of application, Ser. No. 720,563,filed Sept. 7, 1976now abandoned.

Of the great variety of contraceptive techniques presently utilized, orpreviously utilized and no longer advocated, all have definiteundesirable aspects. Surgical techniques are confronted with unavoidableirreversibility; oral/chemical techniques have been shown to includecertain undesirable side effects. Interuterine contraceptive deviceshave not been altogether satisfactory and, while such devices may beeffective in preventing conception, there exists evidence of some localas well as systemic difficulties in a certain proportion of users;further, inconvenience attending the use of interuterine devices, suchas the requirement for trained medical personnel for application,militates against their use.

Both intrauterine devices and oral contraceptives have recently beensubject to criticism, suggesting heretofore unrealized or unrecognizedrisks to the user. With regard to some interuterine devices, recentstudies pertaining to the biology of trace elements may suggest that thepresence of copper in interuterine devices is a potential source ofmetal ions effective in catalyzing lipid peroxidation. With regard tooral contraceptive systems, it has been shown that they decrease serumzinc content and often increase copper content in the serum. Zinc isknown to contribute to the integrity of biomembranes of cells andreactivity of tissues; further, zinc supplementation has been shown toinhibit platelet aggregation, the release of serotonin and also to limitthe necrotic changes in the heart after isoproterenol. Decreased zinccontent in the plasma following the ingestion of certain oralcontraceptives may be the causal factor labelizing platelets increasingtheir aggregability and adhesiveness and thus be a contributing factorto the known enhanced coagulability and thereby probably contribute ahigher incidence of thromboembolism in users of hormonal contraceptivedrugs.

Another, and much older contraceptive technique is the utilization of anintravaginal material. Basically, intravaginal contraception techniquesmay be divided into three general approaches used or suggested by theprior art; first, chemical techniques (e.g. jells, foams, and the like,incorporating spermicidal agents and/or astringents); second, occlusivessuch as diaphragms or cervical caps; and third, tampon devices. Thesetechniques, as used today, could be considered safer to the user than inprevious ages; they are, however, inefficient and inconvenient. Thepresent invention relates to the third category of intravaginaltechniques but offers safety, efficiency and convenience.

The utilization of intravaginal tampons to prevent conception wouldappear to be at least over two thousand years old. Certain types oftampons constructed from plant derivatives apparently were utilized as ameans of introducing spermacidal chemicals in Egypt as early as 1550B.C. Throughout succeeding centuries substances such as cotton or woolwere used as intravaginal contraceptive devices; during the Middle Agesthere seems to have been some use of vegetable pulps as tampon material.There is some suggestion that during the period corresponding to theMiddle Ages oriental cultures used a form of bamboo paper as anintravaginal contraception device. In more recent times, approximatelythe Sixteenth Century, there appears to be some evidence of the use of asea sponge as an intravaginal contraceptive device while in theEighteenth and Nineteenth Centuries sponges were sometimes moistenedwith dilute lemon juice or brandy as a spermicidal agent. More recently,rubber and natural sponges have been used and moistened with suchalleged spermacidal agents as olive oil. Present day attempts to useintravaginal sponge devices sometimes incorporate a more sophisticatedagent such as currently available foams.

Presently, the use of a sponge in combination with a spermacidal foamhas been characterized as an inexpensive but relatively ineffectualcontraceptive technique. Such prior art sponge contraceptive techniquerequires the insertion of the sponge into the vagina immediately beforeintercourse where it will remain effective for only a matter of hours;the sponge must remain in place for a period of several hours, usuallysix, following the last act of coitus. Any attempt to permit the spongeto remain longer is accompanied by physiologically unacceptable effects.The intravaginal contraception system of the present inventionemphasizes the long term use of an intravaginal contraceptive spongehaving unique properties permitting such extended use without adversereactions.

Prior art attempts to provide a successful intravaginal contraceptivedevice and method through the use of various materials have generallyfailed to meet the requirements of efficient and convenient intravaginalcontraception. A variety of sponges and sponge-like structures have beensuggested, including those constructed of polyethelene foam,silico-organic rubber, neoprene, and a variety of polymers; however, ineach instance, the disadvantages have prevented significant use.

There are several disadvantages with prior art attempts to preventconception through the utilization of intravaginal tampon devices. Forthe device to be effective, it must dependably prevent sperm fromreaching the cervical uterine canal. It is known that due to a pH offrom 4 to 5 in the vagina, under normal physiological conditions, themotility and viability of spermatozoa in the vagina is limited to arelatively short time period of approximately 1 to 2 hours; in contrast,motility and viability of the spermatazoa is preserved for up to 48hours in the uterine tract. It is therefore incumbent upon anyintravaginal contraceptive method and device to totally prevent thepassage of spermatozoa and maintain such blockage for at least thelifetime of the most optimistic sperm. To provide a mechanical blockage,it is therefore important for any device to form an intimate contactwith the walls of the vagina while covering the cervix and to maintainthe contact regardless of the expansion, contraction, change incross-sectional configuration or other movement of the vagina and thewalls thereof.

The resilience of the device must therefore provide intimate contactwith the walls of the vagina while providing sufficient force againstthe walls to prevent dislodgement. The material must be highly absorbentboth as to the volume of liquid which it will absorb and the rate atwhich the liquid is absorbed. Prior art devices including sponges ofvarious compositions do not provide sufficient resiliency, are difficultto maintain in place, and exhibit low rates of liquid absorption and lowtotal liquid capacity. Further, the material should expand while in themoist environment of the vagina to a predetermined size and shape toexert only light pressure while maintaining adherence to the vaginalmucosa. The material must be sufficiently soft to prevent interferencewith normal sexual intercourse and must be non-irritating both to theuser and her sexual partner. The last requirement, if not satisfied, mayresult in itching, discharge, or dyspareunia. Further, the materialshould be capable of being applied without professional assistance andshould be capable of remaining in place for an extended period of atleast several days.

If the intravaginal contraceptive device is formed of a sponge andremains in place as mentioned above, it is imperative that the devicenot interfere with vaginal homeostasis with respect to pH, bacterialflora or cytology and must, of course, not contribute to or cause thegeneration of odor. Prior art intravaginal contraceptive devices fail tomeet the above requirements and have either been abandoned as anineffective contraceptive technique or have been used with less thantotal success.

If the intravaginal contraceptive device is to remain in place for atleast several days, and perhaps for a period of one month, it isimportant that the material be stable as to its physical and biologicalproperties during intravaginal application. However, if the device isalso to be disposable, then it becomes important that the device bebiodegradable in a waste disposal environment. Biodegradability ofcellulose containing materials is established but their useintravaginally for an extended period of time is generally unacceptable.Rubber and polymer compounds may be stable during the period ofintravaginal application but present disposal problems as a result oftheir incompatability with the requirements of biodegradability.

It is therefore an object of the present invention to provide anintravaginal contraceptive device that, when placed in the upper vaultof the vagina proximal to the cervix, will present a mechanical barrierto the passage of spermatozoa.

It is another object of the present invention to provide an intravaginalcontraceptive device that is resilient and will expand in a moistenvironment of the vagina to a pre-formed size and shape.

It is also an object of the present invention to provide an intravaginalcontraceptive device that, when placed in the vaginal proximal to thecervix, will expand and exert light pressure on the walls of the vaginaand adhere to the vaginal mucosa.

It is another object of the present invention to provide an intravaginalcontraceptive device that is highly absorbent and will rapidly absorbliquid, including ejaculate.

It is still another object of the present invention to provide anintravaginal contraceptive that may be placed in the vagina proximal tothe cervix without professional assistance while nevertheless remainingin place without regard to the activity of the user.

It is yet another object of the present invention to provide anintravaginal contraceptive device that, when placed in the vagina, willnot interfere with vaginal homeostasis with respect to pH, bacterialflora or cytology.

It is yet another object of the present invention to provide anintravaginal contraceptive device that, when placed in the vagina, willnot be irritating and will not contribute to itching, discharge ordyspareunia.

It is yet another object of the present invention to provide anintravaginal contraceptive device which, when placed in the vagina for aperiod of several days, will not contribute to the generation of odor.

It is yet another object of the present invention to provide anintravaginal contraceptive device, the physical and biologicalproperties of which remain stable during an extended intravaginalapplication but nevertheless becomes biodegradable when placed in awaste disposal environment.

It is another object of the present invention to provide an intravaginalcontraceptive device incorporating a spermicidal agent which is madeavailable over a period of time greater than that possible with priorart devices.

It is still another object of the present invention to provide anintravaginal contraceptive device comprising a collagenous spongematerial incorporating a drug that is delivered to the vaginal regionduring application of the device over a greater period of time than thatpossible with prior art devices to thereby prolong the pharmacologicalaction of the drugs.

It is another object of the present invention to provide a method ofmaking an intravaginal contraceptive device.

It is another object of the present invention to provide a method ofmaking an intravaginal contraceptive device comprising collagen spongereconstituted in molds resembling the formal anatomy of the upper vaultof the vagina proximal to the cervix.

It is still another object of the present invention to provide a methodof making an intravaginal contraceptive device comprising collagensponge reconstituted to provide a resilient structure incorporating a pHapproximating the natural pH of the vagina.

It is another object of the present invention to provide a safe,convenient and effective method for preventing conception.

It is still another object of the present invention to provide a methodfor preventing conception by blocking the passage of spermatozoa fromthe vagina to the uterine canal while subjecting the sperm to anenvironment hostile to their existence but nevertheless normal to thevagina.

These and other objects of the present invention will become apparent tothose skilled in the art as the description thereof proceeds.

The present invention may be described by reference to the accompanyingdrawings in which:

FIG. 1 is a perspective view of a collagen sponge contraceptive deviceconstructed in accordance with the teachings of the present invention.

FIG. 2 is a front elevational view of the device of FIG. 1.

FIG. 3 is a side elevational view of a mold for receiving collagenslurry for the formation of a collagen sponge contraceptive device.

FIG. 4 is a perspective view of the mold of FIG. 3.

FIG. 5 is a front elevational view of another embodiment of the collagensponge contraceptive device constructed in accordance with the teachingsof the present invention.

FIG. 6 is a perspective view, partly broken away, of the device of FIG.5.

FIG. 7 is an illustration of a mesh structure of incorporation inanother embodiment of the collagen sponge contraceptive device of thepresent invention.

FIG. 8 is a perspective view, partly broken away, of another embodimentof the present invention incorporating the mesh of FIG. 7.

FIG. 9 is an illustration of the compression and relaxationcharacteristics of various collagen sponges.

FIG. 10 is an illustration of the rebound characteristics of variouscollagen sponges.

FIG. 11 is an illustration of the resilience of various collagensponges.

The reconstitution of collagen may be accomplished using varioustechniques. The production of such collagen materials, and particularlysponges, incorporates a known process where collagen source materialsuch as bovine skin is comminuted, suspended in water, and frozen, andthe water removed by lyophilisation. Recently, an improved collagenproduct and method for the reconstitution of collagen has beendescribed, i.e. U.S. Pat. No. 3,823,212. In the latter patent, collagenprotein material from a suitable source such as bovine skin ismechanically comminuted, formed into an homogenous slurry in an acidenvironment, a tanning agent is added to the slurry and the slurryfoamed. Subsequently, the slurry is poured into trays and then frozen toa predetermined temperature and incubated for a predetermined time. Theresulting reconstituted collagen product is then available simply bythawing the frozen slurry and mechanically removing excess water;importantly, lyophilisation is not necessary. The specific structureobtained by the above process can be controlled to maximize or minimizephysical characteristics such as resiliency and the like. The control ofthe product is achieved through the control of incubation time,incubation temperature and tanning agent content.

The system of the present invention contemplates an improvement in theprocess of the above-identified patent in the production of a newdevice, and the new use of the device for inhibiting contraception. Inaccordance with the present invention, a collagen sponge is formed fromprepared native collagen derived from various animal tissues rich in thecollagen form of fibrillar protein. The most convenient and commonsource of such collagen is bovine skin or Achilles tendons. The tissueis mechanically comminuted and homogenized in an acid environment. Byrepetitive extraction procedures and by specific enzyme digestiontechniques, the noncollagenous material is removed without denaturingthe collagenous protein material. The residual collagen, mostly infibrillar form, is then mixed with distilled water and the pH of theresulting slurry is adjusted to between 3.5 and 6.5 and preferably tobetween pH 4.5 and 5.0 through the addition of acetic acid.

A tanning agent such as glutaraldehyde is then added to the slurry tocrosslink the collagen; after mechanically mixing the suspension, theslurry is poured into molds of suitable size and shape, for example,resembling the formal anatomy of the vaginal fornix with the cervix.

The device of the present invention may be formed as shown in FIGS. 1and 2, having a 6 cm diameter and a 2.5 cm depth, with a centralexcavation 3 cm wide and 1.5 cm deep. The sizes, of course, may bechanged to provide a range of sizes to accommodate expected vaginalcanal sizes. The particular shape of the device is not critical and thedevice may alternatively be formed through the use of a mold such asshown in FIGS. 3 and 4 to provide a shape more closely comporting withthe upper vault of the vagina at the fornix with a central cavity moreclosely conforming to the shape of a typical cervix. Furthermodifications may be made in the specific shape and structure of thedevice. For example, FIGS. 5 and 6 disclose a device having a diameterand cavity size and shape corresponding to the device of FIGS. 1 and 2;however, additional radial force may be derived from the structure ofFIGS. 5 and 6 through the inclusion of a stiffening member or ring 10formed of rubber or stainless steel. The embodiment shown in FIGS. 5 and6 inherently incorporates a radial stiffness which is believedunnecessary except in specific circumstances. Similarly, stiffness maybe added to the device structure through the utilization of a nylonfiber mesh screen as shown in the embodiment of FIGS. 7 and 8. The nylonfiber mesh also permits the sponge to more readily maintain apredetermined shape and continuously exert sufficient pressure on thevaginal wall to retain its position proximal the cervix. Under certaincircumstances, it may be desirable to add to the stiffness or "springrate" of the device through the addition of elements such as thestiffening member 10 of FIGS. 5 and 6 of the mesh of FIGS. 7 and 8;further, it may also be desirable to assist the maintenance of apredetermined shape through the incorporation of the mesh of FIGS. 7 and8. However, the method of the present invention produces a collagensponge having such mechanical properties that such additional elementsare usually not necessary.

The suspension is reconstituted into collagen sponge by freezing theslurry at approximately -10° centigrade and incubating the frozen slurryfor approximately 20 hours. The frozen mass is then thawed and the bulkof the water is removed by mechanical squeezing of the resultingcollagen sponge. Collagen sponge is thus crosslinked by mono orbiofunctional aldehydes (for example glutaraldehyde) and reconstitutedby the described freezing procedure into the sponge. Glutaraldehydereacts with E-amino groups of collagenous lysine or hydroxylysine aminoacids under the formation of Schiff bases. ##STR1##

SCHIFF BASE CROSSLINK

Schiff base is known to be unstable in acid environment. Thusequilibration of the sponge with an acetate buffer to an acid pH, to bedescribed later, may result in continuously breaking of Schiff bases; asa result, the sponge will lose its resilience (which depends on thenumber of crosslinks) and eventually its desirable physicalcharacteristics. To prevent such decomposition of this form of crosslinkSchiff base, it must be reduced, by any reducing agent, optimally bysodium borohydride (NaBH₄) alkali medium of pH 8 to 9.

By this reaction, the double bond in Schiff base is reduced to a single,very stable bond, resistant to acid treatment. ##STR2## Accordingly,reconstituted and glutaraldehyde-crosslinked sponge, when thawed, iswashed 5 times in tap water to remove any free aldehyde; then the pH ofthe wash is adjusted by sodium hydroxide to pH 8 to 9. Sufficient sodiumborohydride is then added to the wash to create excess reducingequivalents. The sponge is then incubated at 20° C. for 2 hours in thewash. The washed sponge is then soaked for 30 minutes to 2 hours(sufficient time to equilibrate to uniform pH) in a buffer solution ofpH 4 to 5; for example, a 0.1 to 0.5 M acetate buffer, pH 4.1. Thesolution is mechanically removed and the sponge dried in the air.

Any buffer system operating efficiently within the range of pH 4.0 to5.0 could be used in order to maintain the relative concentration ofhydrogen ions in the vagina environment stable. This means that anefficient buffer has a certain strength to neutralize the effect ofliquids (cervical mucus, ejacuate) having slightly alkali pH. Thus,acetate or citrate buffers may be used of molar strength ranging from0.1 to 1 M solutions to equilibrate and preserve the pH of the collagensponge in a range of 4.0 to 7.0 and preferably to 5.0 to 6.0.

The sponge may then be immersed in a surfactant such as a solution ofapproximately 0.1% Triton X-100 (a commercial name for octyl phenoxypolyethoxyethanol).

There are two significant advantages accompanying the application ofbiologically inert surfactants to the sponge. First, the surfactantincreases the rate of wetting of dry sponge by any fluid, ejaculateincluded. Thus, by such a treatment the rate of flux of sperm into thesponge will be increased. Second, surfactants, specifically Triton-X-100are known spermicidal agents, used in commercially available vaginalspermicidal preparations. Alternatively, the surfactant may be added tothe buffering solution and supplied to the collagen sponge concurrentlywith the equilibriated buffer.

The mechanical strength of the collagen sponge may be enhanced by theaddition of cellulose fiber to the collagen material. When cellulose isto be added, a fibrillar cellulose material such as viscose may be addedto the slurry; preferably, the material is in the form of fibers ofapproximately 0.5 to 2 cm in length and approximately 50u to 150u,preferably 100u in diameter. An amount of cellulose, in fibrillar form,equal to approximately 5% to 15%, and preferably 10% of the dry weightof collagen, is added to the slurry prior to reconstitution of thecollagen. The resulting sponge exhibits substantially the samecharacteristics as the collagen sponges without the cellulose fiberaddition but is somewhat mechanically stronger and more resistant tophysical damage such as tearing.

Although the reconstitution of collagen by the freezing procedure willproduce structures from felt-like consistency to soft sponges; thereexists an optimum combination of parameters insuring the production ofthe desired sponge for contraceptive purposes. These parameters havebeen found to be as follows: the temperature of freezing should bewithin 0° to -20° centigrade, preferably about -5° centigrade, time ofincubation of frozen slurry should be from 12 hours to 3 days,preferably about 20 hours, the amount of tanning agent, such asglutaraldehyde, should be 0.5-1% based on the total volume of theslurry.

EXAMPLE 1

A 100 ml collagen slurry was formed having a collagen content of 1% (dryweight basis). The mixture was homogenized by mechanically mixing toform a collagen slurry foam while 0.5 ml gluraldehyde was added. Thefoamed collagen was poured into molds, each having a 6 cm diameter and a2.5 cm depth with a central excavation 3 cm wide and 1.5 cm deep. Thecollagen thus placed in the molds was then frozen at -5° C. for 20hours. The frozen slurry was allowed to thaw at room temperature; waterwas then mechanically removed from the foamed collagen sponge bysqueezing the thawed structures. The sponge thus formed was then washedfive times in tap water and then immersed in a 500 ml tap water washadjusted to pH 8 by the addition of sodium hydroxide. Two grams ofsodium borohydride were then added to the wash to ensure an excess ofreducing medium; the sponges were then incubated at 20° C. for 2 hoursin the wash. The sponges were then removed, washed in tap water, andthen immersed in an 0.4 M acetate buffer solution for a period of onehour. The sponge was then removed, and the excess solution mechanicallyremoved by squeezing; the sponges were then allowed to dry in air.

EXAMPLE 2

The procedure described in Example 1 was repeated except that viscosefibers were added to the homogenized collegen mixture. The viscosefibers had an average length of 1.5 cm and an average diameter of 100u.The amount of fiber added equaled approximately 10% of the dry weight ofcollagen (0.1 grams).

EXAMPLE 3

The procedure described in Example 1 was repeated and the resultingsponges were then immersed in an 0.1% solution of Triton X-100. Thesesponges were then removed and excess solution was mechanically squeezedtherefrom; the sponges were then all allowed to dry at room temperature.

An intravaginal contraceptive sponge formed by the above method exhibitsa pore size varying between 80u and 1400u with an average size of 400u.The pH of an extract of the sponge will range between pH 4.0 to 7.0 andpreferably between pH 4.5 to 6.0. The density of the sponge will rangefrom 30 to 45 mg/cm³. The sponge matrix incorporates a continuity ofchannels which, in combination with the above pore size, produces anunexpectedly high capillary pressure (or suction), thus yielding a veryhigh rate of liquid binding as may be seen by reference to the followingTable 1:

                  TABLE 1                                                         ______________________________________                                        Liquid Binding by Various Sponges                                                                        Rate of Binding                                                               g H.sub.2 O/g/15 sec.                                              Total Binding                                                                            in % of total                                      Type of Sponge  g H.sub.2 O/g                                                                            binding                                            ______________________________________                                        Collagen sponge - partially                                                                    23        55                                                 crosslinked                                                                   Collagen sponge - maximum                                                                     45         78                                                 crosslinked                                                                   Polyvinylalcohol                                                                              19         10                                                 Polyurethane    31         12                                                 Teflon          0          0                                                  Cellulose       9          38                                                 Cotton          8          42                                                 ______________________________________                                    

With reference to the above table, it may be seen that the collagensponge produced in accordance with the method described above exhibits aunique capacity for liquid binding as well as an extremely high rate ofbinding. Further, in the other materials listed in the table, it may beseen that a high total binding is not accompanied by a high ratebinding. The polyvinylalcohol, polyurethane and Teflon materials arecommercially available sponge materials; the cellulose and cottonmaterials are those used in commercial hygenic vaginal tampons.

As stated previously, various characteristics of the sponge of thepresent invention are controlled by varying certain parameters, withinthe stated ranges, in the reconstitution of the collagenous mass. Therelationships of resiliency, rebound and relaxation characteristics withcrosslinking are shown in FIGS. 9, 10, and 11. Three collagen spongeswere prepared, each differing in the degree of crosslinking; thevariation in crosslinking was achieved by altering the glutaraldehydecontent in the foamed slurry prior to reconstitution. Each of thesponges was rated as a function of the crosslinking (degree of tanning)by determining the shrinkage temperature of the collagen. It is wellknown that the crosslinking in collagenous material is destroyed bysubjecting the wetted collagen to elevated temperatures. The destructionof such crosslinking is initially evidenced by a marked shrinkage of thesponge; a requirement of a higher temperature to cause initial shrinkingindicates a higher degree of crosslinking. Accordingly, the threesponges represented in FIGS. 9, 10, and 11 as sponges A, B, and C wererated in accordance with the degree of crosslinking present in therespective sponges by ascertaining the shrinkage temperature T_(s)measured in degrees Centigrade.

Table II illustrates the relationship between degree of crosslinking (asdetermined by T_(s)) and the rate and magnitude of liquid bindingcapacity of the collagen sponge. In fact, collagen sponge withoutcrosslinking collapses when placed in contact with water and servesbetter as a homeostatic agent than as an absorbent medium.

                  TABLE II                                                        ______________________________________                                        Effect Of Crosslinking Of Collagen Sponge                                     On The Rate And Magnitude Of Liquid Binding Capacity                                                     Rate of Liquid                                     Degree of Cross-                                                                          Liquid Binding Binding g H.sub.2 O/g/10                           Linking T.sub.s (°C.)                                                              g H.sub.2 O/g Dry Sponge                                                                     Sec.                                               ______________________________________                                        48          12              4                                                 56          27             15                                                 62          37             30                                                 69          45             45                                                 ______________________________________                                    

The device prepared in accordance with the above method exhibits afelt-like consistency in the dry state. The dry sponge is immersed inwater prior to insertion in the vaginal canal and may readily becompressed to approximately 10% of its original size in its moistcondition; this reduced size renders the application of the devicesimple, thereby permitting self-administration without the aid of anyapplicator. It will be obvious, however, that the sponge may be insertedin the vagina through the use of an applicator similar to that presentlyused for various types of hygenic vaginal tampons. Upon depositionwithin the vaginal canal proximal to the cervix, the moistened spongepromptly expands to its original size and shape as shown in FIGS. 3 and4. In this state, the sponge will make intimate contact with the vaginalmucosa and exert a very gentle pressure toward the wall of the fornix;the folding vaginal walls in the vicinity of the fornix will contributeto the force keeping the sponge in place.

The resiliency of the collagen sponge, produced in accordance with theabove method, has been found to be sufficient to exert enough pressureon the vaginal mucosa to maintain its position even during expansion andcontraction of the muscular walls of the vagina. The intimate contactwith the vaginal mucosa by the resilient collagen sponge, prepared asset forth above, accommodates changes in vaginal dimensions duringintercourse while maintaining sufficient frictional force to overcomemechanical forces that may otherwise attempt to dislodge the device,such as pressure fluctuations that may occur in the vaginal tract duringintercourse.

As set forth above in connection with Table I, the collagen sponge, asprepared by the described procedure, exhibits a significantly highertotal liquid binding capacity (2-6 times larger than other testedmaterials) than other sponge materials. A dry collagen spongecontraceptive cup having the above typical dimensions will exhibit anaverage weight of 2 grams with an average liquid binding capacity of 30ml-45 ml of water per gram; therefore, the total liquid binding capacityof the device will normally be from 60-90 ml of water. The averagevolume of ejaculate is approximately 3-5 ml, which, when contacted bythe collagen sponge, and particularly in view of the capillary pressurecreating the high rate of liquid binding capacity, promptly absorbs theejaculate and traps the seminal fluid in the surface layer of thesponge.

The sperm is thus effectively trapped within the framework of the thecollagen sponge and is confronted with an extremely long passageway inany attempted progression through the sponge. As stated previously,motility and viability of spermatozoa in the vaginal environment isgenerally limited to no more than two hours. The device of the presentinvention presents an environment to spermatozoa substantially similarto the normal vaginal environment. The pH of the sponge, unlike priorart devices, effectively duplicates the vaginal environment, thuslimiting the life of spermatozoa coming in contact therewith.Immobilization of spermatozoa in less than 120 seconds has been observedwhen subject to an environment of 4.0 pH. Table III illustrates observedmotility of human spermatozoa in collagen sponge of various pH.

                  TABLE III                                                       ______________________________________                                        Effect Of pH Of Collagen Sponge On                                            The Motility Of Human Spermatozoa                                             pH        Time When Motility Ceased (In Minutes)                              ______________________________________                                        4.0       1.8                                                                 5.0       3.7                                                                 6.0       12.4                                                                7.0       >30                                                                 ______________________________________                                    

This natural spermicidal environment, present in the vaginal canal, isenhanced in the preferred sponge by providing a pH similar to thatextant in the vaginal mucosa. The naturally spermicidal vaginal mucosaand the duplication in the collagen sponge of the naturally occurringacidity (or perhaps even increasing the acidity) provides spermacidalactivity in a manner compatible to, and coincident with, normal vaginalfunctions. The mechanical interruption of sperm migration coupled withthe acid environment presented by the device of the present inventionresults in prompt absorption of the ejaculate into the surface of thedevice and almost instantaneous immobilization of spermatozoa.

In addition to the spermacidal effect of acid pH of the vagina (andcollagen sponge) the low pH is an essential local preventative againstmicrobial and fungus infections in this organ. Accordingly, acidity ofcollagen sponge contributes to the antibacterial and antifungus naturalenvironment of the vagina.

Inorganic zinc or zinc in prostatic fluid or seminal plasma has beenshown to immobilize spermatozoa, to inhibit their respiration andmetabolism of lipids. Correspondingly, the release of zinc from humanspermatozoa as induced by various chelating agents (cystein, EDTA,histidine) is accompanied by a striking increase in oxygen consumptionand in mobility of spermatozoa. Although the effect of zinc on variousfunctions of spermatozoa is not completely understood, the availableliterature indicates a primary inhibitory effect on cell functions. Itis worth mentioning, that a similar effect of zinc has been proposed forgranulocytes, macrophages, platelets, and most cells.

Collagen in the body serves as an ion exchanger binding electrolytes,metabolites, and drugs. The in vivo binding of colloidal gold and othermetals to collagen are other examples of the exchange capacity of thisprotein. Because of the large volume of dicarboxylic and diaminoacid andresidues in the collagen molecule, this protein interacts in vitrol withvarious substances to form complexes of varying chemical stability.

Various binding sites on the collagen molecule permit several types ofmetal binding. Zinc (as well as copper) containing d¹⁰ electrons shouldform stable covalent bonds, although weaker ionic bonds could be formedalso. In addition, simply physical retention of zinc in the fibrillarmeshwork of the porous collagen sponge will render this form of freezinc readily available for a pharmacological effect on spermatozoa.

In view of the unique properties of the contraceptive sponge produced inaccordance with the above method and particularly in view of thephysical properties relating to the ability of the device to be utilizedto prolong the pharmacological action of included drugs, thecontraceptive device can be rendered additionally spermacidal through amodification of the process in its manufacture. Accordingly, to thepreviously described acidified collagen slurry containingglutaraldehyde, zinc chloride solution is added to obtain 100-500 uMfinal concentration and the method described above is followed toreconstitute the collagenous protein in contraceptive sponge form. Theretention of the zinc compound through molecular binding as well asphysical entrapment in the interstices of the sponge presents a uniquespermacidal releasing structure.

Alternatively, the formed contraceptive collagen sponge may be immersedin a 100 to 500 uM zinc acetate solution for approximately 30 minutes.The sponge is removed from the solution and the excess solutionmechanically removed. This latter addition of spermacidal compound tothe collagenous sponge provides spermacidal action over a periodconsiderably prolonged relative to the utilization of the samespermacidal solution in a non-collagen sponge. The physical andmechanical properties of the collagen sponge of the present inventionprovide a more intimate capture of the solution and a more regulatedrelease of the compound during use.

One of the major problems in gynecology are virus infections of thevagina and adjacent tissues by herpes simplex virus. It has been shown,however, that multiplication of rhinovinus, which consists basically ofsimple ribonucleic acid molecule, is inhibited by zinc. Zinc is known tolink to RNA or DNA molecules thus preventing virus division. Thus,combination of collagen sponge with Zn++ as proposed above will not onlyincrease spermicidal-contraceptive efficacy of collagen sponge but willalso have pharmacological-therapeutic effect in situations of herpeticinfections.

The unique physical properties of the contraceptive collagen spongeprepared in accordance with the above method as well as the molecularbinding capacity of the device provides an unusual drug delivery system.In the treatment of bacterially related disease involving the vaginalcanal, the contraceptive sponge of the present invention may be utilizedto incorporate bactericidal compounds for prolonged administration tothe affected areas. The bactericidal agent may be incorporated into thecollagenous structure through the addition of a bactericidal solutioninto the aforementioned slurry prior to reconstitution of the collagenmaterial. The drug delivery system thus made available provides anunusual means for continuously administering and prolonging thepharmacological action of the bactericide. The unique physicalproperties of the collagen sponge including the liquid binding capacityof the sponge, as well as the structural characteristics of the sponge,provide an excellent means for absorption of bactericidal solutionsprior to application of the device to the vaginal canal. The unusualretention characteristic of the sponge again prolongs thepharmacological action of the bactericidal drug captured in theinterstices of the sponge. The intravaginal contraceptive sponge of thepresent invention may therefore serve the role of continuous protectionagainst Neisseria gonorrhea, treponema pallidum (syphilis), and othersexually transmitted micro-organisms when used for the administration ofanti-venereal disease prophylactic drugs. For example, additions to thecollagen sponge such as ortho-iodobenzoic acid, 0.1% napharsen, 1%sodium lauryl sulfate would provide the user with continuity of theprotective effect, convenience, and long exposure of micro-organisms tothe drug, without interference with the sexual act. At the same time itwas shown that the above additions to the present collagen sponge arespermicidal, thus increasing the contraceptive role of the collagensponge.

The collagen sponge prepared in accordance with the teachings of thepresent invention has been found to retain its unusual propertiesthroughout its period of use in intravaginal applications. The materialdoes not exhibit any degradation during storage or use; however, thecollagen sponge does exhibit biodegradability when placed in a wastedisposal environment. While no quantified measurements were takenconcerning the biodegradability of the collagen sponge contraceptivedevice of the present invention, the biodegradability was demonstratedby immersing samples of the devices in a typical sewage effluent. Thetemperature was maintained at 20° C. for one group under test and at 37°C. for another. The sponges were immersed in the effluent and wereremoved at predetermined times to evaluate cohesion. No quantititativemeasurements could be taken; however, observations were made concerningthe degradiation of the sponges through their respective loss ofinherent cohesion. The following Table IV illustrates thoseobservations. A zero ("0") in the table indicates that no visible changeoccurred in the structure of the sponge when observed by the unaided eyeand manually removed from the effluent and agitated. Each positive sign("+") indicates an arbitrarily chosen degree of disintegration resultingfrom loss of cohesion of the corresponding sponge; entry in the table offour successive plus signs indicates that the sponge became totallydisintegrated, suggesting a breakdown in the fibrillar structure of thesponge and digestion of the protein.

                  TABLE IV                                                        ______________________________________                                        DEGRADATION OF CSC IN SEWAGE SYSTEM                                           DEGREE OF DIGEST IN DAYS                                                      7          14      21     28     35     42                                    ______________________________________                                        At 20° C.                                                                      0      0       ± ++     +++    ++++                                At 37° C.                                                                      0      0±   +    +++    ++++   ++++                                ______________________________________                                    

EXAMPLE 4

Several samples were prepared by the procedure described in Example 1except that the sponges were molded with a 6 cm diameter and 2.5 cmdepth without a central excavation. Each sponge had the characteristicsshown below in Table V:

                  TABLE V                                                         ______________________________________                                        Size - diameter of cylinder                                                                            60 mm                                                thickness                25 mm                                                Dry weight (g)           2.08 ± 0.05                                       pH                       4.5 - 5.0                                            Density (mg/cm.sup.3)    37.6 ± 2.0                                        T.sub.s °C.       75 ± 4                                            Water binding capacity (a) (g H.sub.2 O/g)                                                             45 ± 5.0                                          Rate of wetting (b) (g H.sub.2 O/g/10 sec)                                                             41 ± 3.0                                          Resilience (c) (g)       695 ± 20                                          Rebound (d) (in % of original thickenss)                                                               97 ± 3                                            ______________________________________                                         (a) Refers to total volume of water trapped and bound inside the sponge.      (b) Measured with prewetted sponge to simulate the in vivo situation.         (c) Refers to pressure in grams needed to compress wet sponge to 50% of       original thickness.                                                           (d) Refers to extension of sponge compressed as described under (d) 60        sec. after removing the load. Value is given in percent of original           thickness of the sponge (2.5 cm).                                        

Thirty volunteers having an average age of 27 years were provided withthe above prepared collagen sponges. The sponges were moistened prior touse and the sponges were introduced either through self-administrationor through application by a gynecologist; the sponges were placed in theupper vault of the vagina proximal to the cervix. The collagen spongeswere left in place from a period of 2 days to 27 days between menstrualperiods. No discomfort was reported by any of the users or any of theirsexual partners. Of the 30 volunteers, 25 were classified as sexuallyactive users, 3 of whom reported the incidence of odor occurring after aperiod of 3-4 days which was relieved by removal of the sponge, washingit in tap water, and reinserting it. Each of the volunteers weresubjected to a gynecological examination subsequent to the use of thesponge; no incidence of vaginal irritation or infection was reported bythe inspecting gynecologist. Average retention time was 7 to 9 days whentaking into account the removal of the sponges for evaluation bygynecologists. Average retention time without the removal for evaluationwould have been much higher.

EXAMPLE 5

Contraceptive sponges were prepared as described in Example 4. Threevolunteers self-administered the sponges, after pre-moistening in tapwater, and were inserted in the upper vault of the vagina proximal tothe cervix. The sponges were inserted prior to intercourse and remainedin situ for a period of from 2 to 8 hours after intercourse. The spongeswere subsequently removed by gynecologists and a sperm penetrationexamination conducted in the cervical mucosa of each volunteer. No spermpenetration could be found.

EXAMPLE 6

Several sample sponges were prepared as set forth in Example 4, werepre-moistened in tap water, and were self-administered by threevolunteers by insertion in the upper vault of the vagina proximal to thecervix. Coitus was simulated and orgasm induced in the volunteersthrough the utilization of an artificial penis within which was mounteda duodenoscope to permit continuous filming of the sponge during orgasm.The sponge was observed to continuously cover the cervix of the uterusand maintain intimate contact with the vaginal walls.

While the present invention has been described in the light of humanuse, it will be obvious to those skilled in the art that the process,the product and its use are applicable to those animals whose anatomicaldescription includes reproductive organs equivalent to the human vaginaltract.

What is claimed is:
 1. A contraceptive device for insertion in the uppervault of the vagina proximate the cervix comprising:(a) a reconstitutedcollagen mass having a size and shape for insertion in the upper vaultof the vagina; (b) said collagen mass having a porous sponge structurewith pore diameters ranging from 80u to 1400u.
 2. The contraceptivedevice of claim 1 wherein the average pore diameter is 400u.
 3. Thecontraceptive device of claim 1 where an extract of said collagen masshas a pH of from 4.0 to 6.5.
 4. The contraceptive device of claim 1wherein an extract of said collagen mass has a pH of from 4.5 to 6.0. 5.The contraceptive device of claim 1 wherein said collagen mass has adensity of from 30 to 45 milligrams per cubic centimeter.
 6. Thecontraceptive device of claim 1 wherein said collagen mass has a densityof from 35 to 40 milligrams per cubic centimeter.
 7. The contraceptivedevice of claim 1 wherein said collagen mass includes cellulose fibersin an amount equal to 5% to 15% of the dry weight of collagen in saidmass.
 8. The contraceptive device of claim 1 wherein said collagen massincludes cellulose fibers in an amount equal to approximately 10% of thedry weight of collagen in said mass.
 9. The contraceptive device ofclaim 1 wherein said collagen mass includes viscose fibers in an amountequal to approximately 10% of the dry weight of collagen in said massand wherein said viscose fibers have a length of from 0.5 to 2centimeters and a diameter of from 50u to 150u.
 10. The contraceptivedevice of claim 1 wherein said collagen mass includes an effectiveamount of a spermicidal agent.
 11. The contraceptive device of claim 1wherein said collagen mass includes an effective amount of zinc chlorideas a spermicidal agent.
 12. The contraceptive device of claim 1 whereinsaid collagen mass includes an effective amount of a bactericidal agent.